NO971448D0 - Anti-Fas rekombinante antistoffer og DNA derfor - Google Patents

Anti-Fas rekombinante antistoffer og DNA derfor

Info

Publication number
NO971448D0
NO971448D0 NO971448A NO971448A NO971448D0 NO 971448 D0 NO971448 D0 NO 971448D0 NO 971448 A NO971448 A NO 971448A NO 971448 A NO971448 A NO 971448A NO 971448 D0 NO971448 D0 NO 971448D0
Authority
NO
Norway
Prior art keywords
fas
dna
recombinant antibodies
recombinant
antibodies
Prior art date
Application number
NO971448A
Other languages
English (en)
Other versions
NO971448L (no
Inventor
Nobufusa Serizawa
Kimihisa Ichikawa
Kaori Nakahara
Shin Yonehara
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of NO971448D0 publication Critical patent/NO971448D0/no
Publication of NO971448L publication Critical patent/NO971448L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39566—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against immunoglobulins, e.g. anti-idiotypic antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1138—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against receptors or cell surface proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO971448A 1996-04-01 1997-03-26 Rekombinante anti-Fas-antistoffer og DNA for disse NO971448L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7857096 1996-04-01

Publications (2)

Publication Number Publication Date
NO971448D0 true NO971448D0 (no) 1997-03-26
NO971448L NO971448L (no) 1997-10-02

Family

ID=13665565

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971448A NO971448L (no) 1996-04-01 1997-03-26 Rekombinante anti-Fas-antistoffer og DNA for disse

Country Status (13)

Country Link
EP (1) EP0799891A1 (no)
KR (1) KR100277769B1 (no)
CN (1) CN1167115A (no)
AU (1) AU724579B2 (no)
CA (1) CA2201185A1 (no)
CZ (1) CZ96397A3 (no)
HU (1) HUP9700676A3 (no)
ID (1) ID16796A (no)
IL (1) IL120553A0 (no)
MX (1) MX9702422A (no)
NO (1) NO971448L (no)
NZ (1) NZ314496A (no)
ZA (1) ZA972726B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996017078A1 (fr) 1994-11-30 1996-06-06 Ajinomoto Co., Inc. Agent antithrombotique et anticorps monoclonaux contre le facteur de von willebrand
ZA982371B (en) * 1997-03-21 1998-09-28 Sankyo Co Humanized anti-human fas antibody
US6972323B1 (en) 1997-04-01 2005-12-06 Sankyo Company, Limited Anti-Fas antibodies
WO1999065935A2 (en) 1998-06-18 1999-12-23 Karolinska Innovations Ab Fas peptides and antibodies for modulating apoptosis
US20030114410A1 (en) 2000-08-08 2003-06-19 Technion Research And Development Foundation Ltd. Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
EP2044122B1 (en) * 2006-07-18 2018-03-28 Sanofi Antagonist antibody against epha2 for the treatment of cancer
IL184627A0 (en) 2007-07-15 2008-12-29 Technion Res & Dev Foundation Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
SI2185198T1 (sl) 2007-08-02 2015-04-30 Gilead Biologics, Inc. Inhibitorji LOX in LOXL2 ter njihova uporaba
WO2010080769A2 (en) 2009-01-06 2010-07-15 Arresto Biosciences, Inc. Chemotherapeutic methods and compositions
SG2014004816A (en) 2009-08-21 2014-03-28 Gilead Biologics Inc Catalytic domains from lysyl oxidase and loxl2
CN102821786B (zh) * 2010-01-29 2016-01-13 阿克西斯股份有限公司 含有骨关节炎治疗剂的注射液
CA2789022A1 (en) 2010-02-04 2011-08-11 Gilead Biologics, Inc. Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor
CN111333720B (zh) * 2020-03-16 2021-11-02 重庆理工大学 抗hpv16e7蛋白单抗79a11、杂交瘤细胞株及其制备方法和应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5620889A (en) * 1993-10-14 1997-04-15 Immunex Corporation Human anti-Fas IgG1 monoclonal antibodies
WO1996040041A2 (en) * 1995-06-07 1996-12-19 Chiron Corporation Antibodies to fas antigen capable of inhibiting apoptosis

Also Published As

Publication number Publication date
IL120553A0 (en) 1997-07-13
HU9700676D0 (en) 1997-05-28
HUP9700676A2 (hu) 1998-01-28
AU724579B2 (en) 2000-09-28
NZ314496A (en) 1999-02-25
CN1167115A (zh) 1997-12-10
EP0799891A1 (en) 1997-10-08
MX9702422A (es) 1998-03-31
ID16796A (id) 1997-11-13
NO971448L (no) 1997-10-02
HUP9700676A3 (en) 2001-02-28
CZ96397A3 (en) 1997-10-15
ZA972726B (en) 1997-10-23
CA2201185A1 (en) 1997-10-01
KR100277769B1 (ko) 2001-01-15
KR970070198A (ko) 1997-11-07
AU1655297A (en) 1997-10-09

Similar Documents

Publication Publication Date Title
IS1810B (is) Úðablöndur úr peptíðum og próteinum
NO20071415L (no) OB-fusjonsproteinpreparater og fremgangsmater
NO2010013I1 (no) Rekombinant FSH-CTP
IS5158A (is) Genaraðgreinir og aðferðir
NO996551D0 (no) Forbedrete anti-IgE-antistoffer og fremgangsmåte for forbedring av polypeptider
DE69724557D1 (de) Dokumentenanalyse
IS4491A (is) Interferon tengd efni
IS5375A (is) KAY-nýstárlegt ónæmisprótín
DE69836432D1 (de) Bildcoder und -decoder
NO985680L (no) Peptidderivater
NO971448D0 (no) Anti-Fas rekombinante antistoffer og DNA derfor
NO976058L (no) Rekombinant mistellectin
NO983849D0 (no) Peptidderivater
FI970168A (fi) Peptidejä
DE69705017D1 (de) Medikamente bindendes Protein
NO995062D0 (no) <Beta>-anyloidpeptid-bindende proteiner og polynuldeotider som kodes for samme
NO981454L (no) Anti-FAS-antistoffer
TR199701666A3 (tr) Sismanliga karsi proteinler
NO20005547D0 (no) Myelinbasiske proteinpeptider og anvendelser derav
EP1142999A4 (en) PROTEIN AND ITS DNA
EP1111047A4 (en) NEW PROTEIN AND ITS DNA
NO20002832D0 (no) Humantyroidprotein ZSig45 og DNA som koder for dette
NO20006091D0 (no) Humant protein C-polypeptid
SE9602287D0 (sv) Novel protein and methods for its use
KR970012241U (ko) 실험대용 상판

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application